Life Balance
Retatrutide beats Ozempic on weight and A1C in Lilly's head-to-head trial
Lilly says retatrutide cut weight 20-21% versus 9% for Ozempic and lowered A1C more in an 80-week type 2 diabetes trial, October 28, 2026.
28 Oct 2026, 18:41 IST
Peepals Shakti · Topic
A1C
1 story, newest first